It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
We compared the efficacy of nifedipine and ritodrine in the treatment of preterm labor. A total of 135 cases diagnosed to have preterm labor were retrospectively evaluated. Of all the cases 73 and 62 were given nifedipine and ritodrine, respectively. The main outcome measure was the period of delay in delivery. The number of delivered patients within 48 hours were 14 (19.2%) and 23 (37.1%) in patients receiving nifedipine and ritodrine, respectively (p=0.032). Twenty one cases (28.8%) in the nifedipine group and 30 cases (48.4%) in the ritodrine group delivered within 1 week (p=0.022). Thirty cases (41.1%) in the nifedipine group and 37 cases (59.7%) in the ritodrine group delivered before 35 weeks of gestation (p=0.039). There were significantly lower maternal side effects in the nifedipine group than in the ritodrine group. The number of newborns transferred to the neonatal intensive care unit was significantly lower in the nifedipine group when compared to the ritodrine group (p<.05). Nifedipin treatment, when compared to ritodrine, is more effective in delaying labor in the management of preterm labor. On the basis of the results of the present study we conclude that use of nifedipine is more effective in the treatment of preterm labor when compared to ritodrine treatment.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer